IDEAYA Biosciences (IDYA) Stock Statistics & Valuation Metrics

IDEAYA Biosciences has a market cap or net worth of $3.55B. The enterprise value is $2.63K.

IDEAYA Biosciences has 96,489,490 shares outstanding. The number of shares has decreased by -2.65% in one year.

IDEAYA Biosciences’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -15.16%.

The current PE Ratio of IDEAYA Biosciences is ―. IDEAYA Biosciences’s PEG ratio is 0.44.

In the last 12 months, IDEAYA Biosciences had revenue of 218.71M and earned -113.70M in profits. Earnings per share was -1.28.

In the last 12 months, operating cash flow was -186.83M and capital expenditures -3.17M, giving a free cash flow of -190.01M billion.

IDEAYA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

IDEAYA Biosciences upcoming earnings date is Nov 10, 2026, After Close (Confirmed).

IDEAYA Biosciences as a current ratio of 11.34, with Debt / Equity ratio of 2.44%

In the past 12 months, IDEAYA Biosciences has paid 0.00 in taxes.

IDEAYA Biosciences EV to EBITDA ratio is -19.22, with an EV/FCF ratio of -40.48.

IDEAYA Biosciences has $828.96M in cash and marketable securities with $29.31M in debt, giving a net cash position of $799.65M billion.

Gross margin is -13.32%, with operating margin of -72.84%, and net profit margin of -51.99%.

The average price target for IDEAYA Biosciences is $51.55, which is 11.43% higher than the current price. The consensus rating is Strong Buy